Introduction

After more than 25 years without new options, U.S. shoppers can finally choose a sunscreen filter that European consumers have relied on for years. The FDA's June 2026 approval of bemotrizinol marks the first major addition to American sunscreen shelves since the late 1990s.

What Happened

The Food and Drug Administration granted approval to bemotrizinol, known by its shorthand BEMT, after reviewing safety data from over 500 patients conducted by DSM Nutritional Products. The ingredient will appear in new formulations from major brands, including Neutrogena, and will join existing mineral filters like zinc oxide and titanium dioxide on store shelves.

Why This Matters

BEMT fills a critical gap by providing broad-spectrum protection against both UVA and UVB rays without the cosmetic downsides that deter some users. Unlike older chemical filters, it absorbs minimally into the skin, resists breaking down in sunlight, and avoids the white streaking associated with mineral-based options, making it especially appealing for people with darker complexions.

Key Takeaways

  • BEMT offers broad-spectrum UVA/UVB protection without the white cast of traditional mineral sunscreens.
  • The ingredient has minimal skin absorption, and the FDA classified it as "generally recognized as safe and effective."
  • It is significantly more stable than avobenzone, a common U.S. filter that degrades quickly under sun exposure.
  • New products from Neutrogena and other manufacturers are now available, expanding consumer choice.
  • Despite its safety profile, experts still recommend reapplying sunscreen every two hours and combining it with shade, hats, and protective clothing.

Conclusion

The arrival of bemotrizinol gives Americans a long-awaited alternative that balances strong protection with better skin feel and environmental considerations. As with any sunscreen, dermatologists emphasize that it works best as part of a broader sun-safety strategy, including seeking shade and wearing sun-protective gear outdoors.